Global Consolidated Aesthetics Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Global Consolidated Aesthetics Limited - overview
Established
2007
Location
Dublin, -, Ireland
Primary Industry
Medical Devices & Equipment
About
Global Consolidated Aesthetics Limited specializes in advanced aesthetic products, primarily focusing on high-quality breast implants that enhance the cosmetic and reconstructive needs of patients worldwide. Founded in 2007, Global Consolidated Aesthetics Limited operates out of Dublin, Ireland, providing breast augmentation solutions. In January 2022, the company raised EUR 4. 4 million in venture funding from Barry's Tea Holdings, reaffirming its commitment to product innovation and market expansion.
The company has successfully completed 6 deals since its inception. GC Aesthetics® specializes in breast augmentation products, focusing on high-quality breast implants designed for aesthetic enhancement and reconstructive purposes. Their flagship GCA® Breast Implants offer a natural feel and appearance, backed by an extensive warranty program, and are available globally across North America, Europe, and Asia. The company collaborates with healthcare professionals, including board-certified plastic surgeons, to facilitate surgical procedures.
In 2021, Global Consolidated Aesthetics Limited reported a revenue of EUR 45. 91 mn, with an EBITDA of EUR -3. 77 mn. Revenue is primarily generated through the sale of breast implants and related products, engaging both direct-to-consumer and business-to-business transactions.
Following the EUR 4. 4 million funding in January 2022, GC Aesthetics aims to further develop its product line, specifically introducing new breast augmentation solutions. The company is actively pursuing expansion into new markets in Asia and South America by the end of 2023, with a focus on increasing accessibility to its innovative products. The recent funding will support these initiatives, enhancing production capabilities and marketing efforts.
Current Investors
Montreux Equity Partners, Oyster Capital Partners, Barry's Tea Holdings
Primary Industry
Medical Devices & Equipment
Sub Industries
Aesthetic Medicine, Medical Equipment Distributors
Website
www.gcaesthetics.com
Company Stage
Series D
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.